Aminolevulinic Acid Hydrochloride Freeze-Drying for Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Aminolevulinic acid hydrochloride has poor stability in solution form, leading to degradation and impurity formation, and its freeze-drying process is challenged by dense crystal nuclei formation, low eutectic point, and collapse during sublimation, affecting product appearance and quality.
Innovation Solution
A controlled freeze-drying process involving specific concentration, filling volume, temperature gradients, and vacuum conditions is employed, including pre-freezing, sublimation stages, and stoppering to produce stable freeze-dried formulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If aminolevulinic acid hydrochloride is formulated as a solution, then it has good water solubility and can be easily administered, but it degrades rapidly and produces impurities
Solution Approach 1:
The patent applies freeze-drying technology to transform the drug from liquid solution phase to solid freeze-dried cake phase. This phase transition removes water from the system, converting the unstable aqueous solution into a stable anhydrous or low-moisture solid form that resists degradation and impurity formation, while maintaining the drug's therapeutic efficacy.
2Stability of the object's composition
If freeze-drying is applied to aminolevulinic acid hydrochloride, then stability is improved and transportation is convenient, but dense crystal nuclei form during pre-freezing causing sublimation problems
Solution Approach 1:
The patent systematically optimizes freeze-drying parameters including pre-freezing temperature (-40°C to -80°C), sublimation temperature gradient, vacuum pressure (0.01-0.1 MPa), and drying time. These parameter changes control the nucleation and crystal growth processes, preventing dense crystal formation while enabling complete sublimation, thus resolving the manufacturing difficulty without compromising stability improvements.
Solution Approach 2:
The patent employs dynamic adjustment of freeze-drying conditions throughout the process. The temperature is gradually increased from deep freezing to sublimation temperatures, and vacuum pressure is dynamically controlled to facilitate progressive water removal. This dynamic approach allows the system to adapt to changing physical states of the drug matrix, preventing collapse and ensuring complete drying.
3Quantity of substance
If the concentration of aminolevulinic acid hydrochloride solution is increased, then less volume is needed for administration, but crystal nuclei become denser during pre-freezing
Solution Approach 1:
The patent optimizes the concentration parameter within a specific range (10-50 mg/mL) to balance dosing efficiency with freeze-drying performance. At these optimized concentrations, the drug molecules are sufficiently concentrated to reduce administration volume but not so concentrated as to cause excessive crystal nucleation density, thereby simplifying the freeze-drying process while maintaining therapeutic efficacy.
4Ease of operation
If the eutectic point and collapse temperature are low, then the drug solution is easier to handle, but sublimation is hindered and the product collapses
Solution Approach 1:
The patent employs dynamic temperature programming during sublimation, gradually increasing temperature from the low eutectic point to above the collapse temperature in controlled stages. This dynamic approach allows water to sublime completely at lower temperatures first, then gradually raises temperature to prevent collapse during the final drying stages, ensuring both ease of handling and high product quality.
Solution Approach 2:
The patent performs preliminary deep freezing before sublimation to establish a stable ice crystal structure. This preliminary action ensures that water is fully frozen and properly structured before the sublimation process begins, preventing collapse during subsequent heating even when the collapse temperature is low, thereby maintaining product appearance quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process prevents floating, re-dissolving, and collapse of the drug cake, ensuring the freeze-dried product meets quality and appearance standards with controlled moisture and impurity levels.
Implementation Method 1
the eutectic point and collapse temperature of the drug solution are low, which is not conducive to the sublimation of water
Implementation Method 2
If it is developed into a freeze-dried formulation, the stability of the formulation can be improved
Implementation Method 3
1. Drying under low temperature conditions can reduce the degradation of heat-sensitive products
Data Source
AI summary
An aminolevulinic acid hydrochloride freeze-dried formulation and a preparation method thereof are provided. With the character, moisture, related substances, and content of the aminolevulinic acid hydrochloride freeze-dried formulation as evaluation indicators, the processes such as temperature, rate, time, repeated freezing and thawing in the pre-freezing and sublimation process are explored. Meanwhile, the amplified freeze-drying process is optimized, and the character, appearance, and quality of the finished product after freeze drying all meet the requirements.